Ideal Site Selection to Support Patient Recruitment for Personalized Medicine Oncology Studies
Cancer numbers are rising, increasing the need for safe, efficacious and cost-effective forms of treatment. Often described as personalized or precision medicines, targeted therapeutics tailored to treat cancer with precise genetic mutations is one solution. Because these agents are so precise, they need to be studied in clinical trials designed to recruit the appropriate patient subgroups.
This paper discusses that while finding and recruiting patients by their specific mutational status can speed a drug to market, it can also cause logistical issues, particularly in studies of rare cancers, treatments that use new techniques, or for studies that require specific types of testing.